MENU

Statement of the DDB on the change of leadership in the Philippine Drug Enforcement Agency

The Dangerous Drugs Board welcomes the assumption of new PDEA Director General Wilkins Villanueva after Malacañang released his appointment signed last 22 May 2020. Incoming DG Villanueva has been a steadfast partner of DDB even during his early years as career officer of PDEA. DDB has involved him in many of its anti-drug efforts particularly in policy formulation and strategy development aspects which helped craft many of its inter-agency priorities all these years. Recognizing him as the 7th Director-General of PDEA, DDB intends to engage more closely and deepen the collaboration with his leadership noting that he will become an Ex-Officio Member of the Board.

Read more ...

DDB Eases the Use of Prescription Forms for Dangerous Drugs

The Dangerous Drugs Board now allows the use of ordinary prescription for medical preparations containing dangerous drugs.

Read more ...

DDB advocates for the use of electronic prescription for dangerous drugs medication

The Dangerous Drugs Board appeals to doctors, pharmacists, and drug store personnel to consider the use of electronic prescription for medicines included in the list of dangerous drugs as the whole country is under a State of Calamity due to the COVID-19 pandemic.

Read more ...

DDB, SDA Church hold program to update health directors on the Philippine Anti-Illegal Drugs Strategy (PADS) and board regulations

The Dangerous Drugs Board, in collaboration with the Southern Asia-Pacific Division of the Seventh-Day Adventist Church, convenes Luzon-based health directors of the religious group to update them on the Philippine Anti-Illegal Drugs Strategy (PADS) and relevant DDB regulations.

Read more ...

DDB clarifies: CBD is not cannabis per se

The Dangerous Drugs Board would like to clarify that marijuana use remains illegal in the country for both recreational and medical use. The use of Cannabidiol, however, is being considered to be allowed for treatment of certain rare forms of epilepsy like Lennox-Gastaut and Dravet Syndrome.

Read more ...

DDB, DOST-FNRI launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

DDB, DOST-FNRI to launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, will officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

PRRD reappoints Cuy as Chairperson of DDB

Secretary Catalino S. Cuy was given a fresh mandate as the Chairperson of the Dangerous Drugs Board (DDB).

This was confirmed after President Rodrigo Duterte signed his reappointment papers on 21 January 2020. Secretary Cuy was first appointed at the DDB in January 2018 serving the remainder of the term of his predecessor.

Read more ...

DDB’s response to the recommendations of the Vice President on the campaign against illegal drugs

The Dangerous Drugs Board notes the recommendations of Vice President Leni Robredo on the anti-drug campaign. The agency keeps in mind the ultimate goal of establishing drug-free communities as a serious commitment of the Duterte Administration.

Read more ...

PROFILE OF DRUG ABUSERS
(Facility based)
CY 2005

AGE : Mean age of 29 years
SEX : Ratio of male to female 10:1
CIVIL STATUS : Single 54.40%
FAMILY SIZE : Three (3) to four (4) siblings
OCCUPATION : Unemployed 38.19%
EDUCATIONAL ATTAINMENT : High School level 27.58%
ECONOMIC STATUS:Average monthly family income P13,063.13
PLACE OF RESIDENCE : Urban (specifically NCR)
DURATION OF DRUG TAKING : More than six (6) years
NATURE OF DRUG – TAKING : Poly drug use
DRUGS OF ABUSE : Methamphetamine Hydrochloride (Shabu)
                                 Cannabis (Marijuana)
                                 Inhalants

*Residential and Out-Patient Facility


NUMBER OF REPORTED CASES BY GENDER
(Facility - Based)
CY 2006

                                                   MALE             FEMALE       GRAND TOTAL
TYPE OF ADMISSION NO. % NO. % NO. %
NEW ADMISSIONS 3,858 71.74 366 73.94 4,224 71.62
READMISSIONS 765 14.22 34 6.87 799 13.60
OUT - PATIENT 755 14.03 95 19.19 850 14.47
T O T A L 5,378 91.57 495 8.43 5,873 100.00

 


STATISTICS ON DRUG ABUSE

FACILITY-BASED ADMISSIONS

       For the year 2005, the reporting centers totaled to 55 residential and 3 outpatient facilities, registering an additional 2 residential and another 2 out-patient centers, as compared to those of 2004.

       A total of 5,873 cases were recorded, broken down as 5,023 cases (86%) from the residential facilities and 850 cases (14%) from the outpatient centers.  Out of the total residential cases, 4,224 (84%) were newly admitted while the remaining 799 (16%) were re-admitted cases.  As compared to the figures of 2004, it was noted that there was an increase of 3.55% in the new admissions while there was a 9.92% decline in relapse cases. A significant rise, though, was observed in the out-patient cases from the 2004 figure of 220 to 2005’s total of 850.

       The National Capital Region (NCR) had the highest percent distribution of cases with 3,330 (or 56.70%) of the total national admissions.  Regions IV-A and III followed with 15.21% and 13.18% admissions, respectively.

       Center admissions were predominantly male with a ratio of 10:1.  Single clients comprised 54.40%; married (30.05%); with live-in partners (9.38%); and separated (4.5%).  As to educational attainment, high school level had the highest percent distribution with 27.58%

    Most of these clients were unemployed (38.19%) prior to admission.  For those who were previously employed before undergoing rehabilitation, 32.93% were workers/ employees while 7.59% were self-employed/businessman.  The average monthly family income of these Center clients is 13,063.13

MOST COMMONLY USED/ABUSED DRUGS/SUBSTANCE
(Facility Based)
CY 2005

DRUGS USED / ABUSED

NEW ADMISSIONS
No.          %

RE-ADMISSIONS
No.          %
OUT-PATIENT
No.          %
GRAND TOTAL
No.          %
1. SHABU (STIMULANT) 3,492 59.46 716 12.19 570 9.71 4,778 81.36
2. MARIJUANA (CANNABIS) 1,178 20.06 324 5.52 474 8.07 1,976 33.65
3. INHALANTS 200 3.41 23 0.39 60 1.02 283 4.82
4. BENZODIAZEPINES 123 2.09 70 1.19 5 0.09 198 3.37
5. COUGH / COLD PREPARATIONS 85 1.45 59 1.00 5 0.09 149 2.54
6. ECSTASY (STIMULANT) 68 1.16 25 0.43 3 0.05 96 1.63
7. COCAINE (STIMULANT) 46 0.78 22 0.37 2 0.03 70 1.19
8. NUBAIN (NARCOTIC / ANALGESIC) 33 0.56 25 0.43 1 0.02 59 1.00
9. OPIUM (MORPHINE / HEROIN) 16 0.27 11 0.19 1 0.02 28 0.48
10. KETAMINE (NARCOTIC / ANALGESIC) 12 0.20 6 0.10   0.00 18 0.31
OTHER DRUGS 7 0.12 1 0.02   0.00 8 0.14

* Total Reported Cases from Residential and Out-Patient Facilities

MOST COMMONLY ABUSED DRUGS

       Filipino drug abusers, being multiple abusers, take drugs in combination with other similarly intoxicating substances.

       For 2005, Methamphetamine Hydrochloride or Shabu, remained as the top drug of choice and was abused by 81.36% (4,778) of clients recorded.  Marijuana was second with 1,976 cases (33.65%) while inhalants placed 3 abused were benzodiazepines (3.37%), cough/cold preparations (2.54%), and Ecstasy (1.63%).

       These drugs were commonly taken through inhalation or sniffing and by oral administration.